Q4 2023 · 13F-HR
JOHNSON & JOHNSON (JNJ)holdings as filed
Filed 2024-02-14 · accession 0000904454-24-000151
$4.39B
Reported value
23
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 49177J102 | KVUE | Kenvue Inc. | $3.93B | 89.5% | 182,329,550 | Common | SHARED |
| 126638105 | CVRX | CVRx, Inc. | $109.9M | 2.51% | 3,495,575 | Common | SHARED |
| 74366E102 | PTGX | Protagonist Therapeutics Inc. | $56.2M | 1.28% | 2,449,183 | Common | SHARED |
| 52490G102 | LEGN | Legend Biotech Corporation | $49.0M | 1.12% | 814,586 | Common | SHARED |
| G59665102 | MGTX | MeiraGTx Holdings plc | $46.6M | 1.06% | 6,641,064 | Common | SHARED |
| 63009J107 | NBTX | Nanobiotix S.A. | $40.9M | 0.93% | 5,623,816 | Common | SHARED |
| 36118A100 | — | Fusion Pharmaceuticals Inc. | $35.3M | 0.80% | 3,670,516 | Common | SHARED |
| 82489T104 | SWAVUSD | Shockwave Medical, Inc. | $31.8M | 0.72% | 166,812 | Common | SHARED |
| 640979100 | NMRA | Neumora Therapeutics, Inc. | $31.5M | 0.72% | 1,849,445 | Common | SHARED |
| 98401F105 | XNCR | Xencor, Inc. | $15.9M | 0.36% | 748,062 | Common | SHARED |
| 74276L105 | PRCT | Procept BioRobotics Corporation | $15.0M | 0.34% | 357,939 | Common | SHARED |
| 31189P102 | FATE | Fate Therapeutics, Inc. | $12.6M | 0.29% | 3,379,064 | Common | SHARED |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals, Inc. | $7.6M | 0.17% | 247,598 | Common | SHARED |
| 929033108 | — | Vor Biopharma, Inc. | $2.4M | 0.06% | 1,074,658 | Common | SHARED |
| M70700105 | NNOX | Nano-X Imaging Ltd. | $2.0M | 0.05% | 317,704 | Common | SHARED |
| 007002108 | TORCEUR | Adicet Bio, Inc. | $1.3M | 0.03% | 688,595 | Common | SHARED |
| 01438T106 | ALDX | Aldeyra Therapeutics, Inc. | $1.1M | 0.02% | 299,669 | Common | SHARED |
| 83444K105 | SLGCUSD | SomaLogic, Inc. | $711,062 | 0.02% | 281,052 | Common | SHARED |
| 09090D103 | — | BiomX Inc. | $597,353 | 0.01% | 2,133,402 | Common | SHARED |
| 185063104 | CLSDUSD | Clearside Biomedical, Inc. | $198,466 | 0.00% | 169,629 | Common | SHARED |
| 81727U105 | SENS1GBP | Senseonics Holdings, Inc. | $31,139 | 0.00% | 54,621 | Common | SHARED |
| 89237H209 | — | Tracon Pharmaceuticals, Inc. | $14,709 | 0.00% | 84,003 | Common | SHARED |
| G0411D107 | APLM | Apollomics, Inc. | $12,788 | 0.00% | 13,252 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.